Thank you

This live web event has ended. Thank you for attending.

Description

Community-based rapid NGS
offers considerable advantages
in clinical cancer care

Why should you register now for this webinar?
Hear about William Osler Health System’s experience with implementing next-generation sequencing (NGS) in routine oncology biomarker testing.

In their pilot study, 578 pan-cancer solid tumor samples underwent genomic profiling.
All testing was performed by one group of technologists within the same division of the laboratory, achieving a median turnaround time (TAT) of 3 business days.

Brought to you by: CAP TODAY
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenter: Brandon Sheffield, MD

What will this webinar empower you to do?

• Elaborate on the importance of timely availability of biomarker results for optimal cancer care
• Demonstrate the feasibility of such TATs in community-based hospitals, using fast and automated NGS
• Describe the novel approach of integrating NGS with routine immunohistochemistry
• Ask questions of our distinguished presenter